Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy.

about

Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy.

Item

http://www.wikidata.org/entity/Q37188501

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Trends in use of anti-thrombot ...... ged with an invasive strategy.

@en

Trends in use of anti-thrombot ...... levation myocardial infarction

@nl

type

Item

label

Trends in use of anti-thrombot ...... ged with an invasive strategy.

@en

Trends in use of anti-thrombot ...... levation myocardial infarction

@nl

prefLabel

Trends in use of anti-thrombot ...... ged with an invasive strategy.

@en

Trends in use of anti-thrombot ...... levation myocardial infarction

@nl

P1476

Trends in use of anti-thrombot ...... ged with an invasive strategy.

@en

P2093

A Y Chen

http://www.w3.org/2001/XMLSchema#string

J A de Lemos

http://www.w3.org/2001/XMLSchema#string

J F Saucedo

http://www.w3.org/2001/XMLSchema#string

K P Alexander

http://www.w3.org/2001/XMLSchema#string

M T Roe

http://www.w3.org/2001/XMLSchema#string

R P Giugliano

http://www.w3.org/2001/XMLSchema#string

R S Gupta

http://www.w3.org/2001/XMLSchema#string

S A Wayangankar

http://www.w3.org/2001/XMLSchema#string

T A Sanborn

http://www.w3.org/2001/XMLSchema#string

P2860

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Bivalirudin for patients with acute coronary syndromes

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Longitudinal data analysis for discrete and continuous outcomes

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Associa

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) init

Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization

P304

464-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IHJ.2015.09.036

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

L Kristin Newby

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27543467

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak

P932

4990733

http://www.w3.org/2001/XMLSchema#string